AAAAAA
Results:
1-17
|
Results: 17
Authors:
Saveanu, A
Morange-Ramos, I
Gunz, G
Dufour, H
Enjalbert, A
Jaquet, P
Citation: A. Saveanu et al., A luteinizing hormone-, alpha-subunit- and prolactin-secreting pituitary adenoma responsive to somatostatin analogs: in vivo and in vitro studies, EUR J ENDOC, 145(1), 2001, pp. 35-41
Authors:
Vallette-Kasic, S
Barlier, A
Teinturier, C
Diaz, A
Manavela, M
Berthezene, F
Bouchard, P
Chaussain, JL
Brauner, R
Pellegrini-Bouiller, I
Jaquet, P
Enjalbert, A
Brue, T
Citation: S. Vallette-kasic et al., PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotrophdeficiency, J CLIN END, 86(9), 2001, pp. 4529-4535
Authors:
Saveanu, A
Gunz, G
Dufour, H
Caron, P
Fina, F
Ouafik, L
Culler, MD
Moreau, JP
Enjalbert, A
Jaquet, P
Citation: A. Saveanu et al., BIM-23244, a somatastatin receptor subtype 2-and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas, J CLIN END, 86(1), 2001, pp. 140-145
Authors:
Vallette-Kasic, S
Dufour, H
Mugnier, M
Trouillas, J
Valdes-Socin, H
Caron, P
Morange, S
Girard, N
Grisoli, F
Jaquet, P
Brue, T
Citation: S. Vallette-kasic et al., Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy, EUR J ENDOC, 143(6), 2000, pp. 761-768
Authors:
Caron, P
Tabarin, A
Cogne, M
Chanson, P
Jaquet, P
Citation: P. Caron et al., Variable growth hormone profiles following withdrawal of long-term 30 mg slow-release lanreotide treatment in acromegalic patients: clinical implications, EUR J ENDOC, 142(6), 2000, pp. 565-571
Authors:
Jaquet, P
Saveanu, A
Gunz, G
Fina, F
Zamora, AJ
Grino, M
Culler, MD
Moreau, JP
Enjalbert, A
Ouafik, LH
Citation: P. Jaquet et al., Human somatostatin receptor subtypes in acromegaly: Distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes, J CLIN END, 85(2), 2000, pp. 781-792
Authors:
Barlier, A
Zamora, AJ
Grino, M
Gunz, G
Pellegrini-Bouiller, I
Morange-Ramos, I
Figarella-Branger, D
Dufour, H
Jaquet, P
Enjalbert, A
Citation: A. Barlier et al., Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: Polymerase chain reaction, triple in-situ hybridization and cell culture studies, J NEUROENDO, 11(7), 1999, pp. 491-502
Authors:
Sassolas, G
Chazot, FB
Jaquet, P
Bachelot, I
Chanson, P
Rudelli, CC
Tauber, JP
Allannic, H
Bringer, J
Roudaut, N
Rohmer, V
Roger, P
Latapie, JL
Reville, P
Leutenegger, M
Citation: G. Sassolas et al., GH deficiency in adults: an epidemiological approach, EUR J ENDOC, 141(6), 1999, pp. 595-600
Authors:
Guieu, R
Dufour, H
Grisoli, F
Jaquet, P
Guieu, Y
Rosso, JP
Munier, M
Dicostanzo, V
Brue, T
Enjalbert, A
Begoud, D
Rochat, H
Citation: R. Guieu et al., An ultrarapid prognostic index in microprolactinoma surgery, J NEUROSURG, 90(6), 1999, pp. 1037-1041
Authors:
Jaquet, P
Ouafik, L
Saveanu, A
Gunz, G
Fina, F
Dufour, H
Culler, MD
Moreau, JP
Enjalbert, A
Citation: P. Jaquet et al., Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas, J CLIN END, 84(9), 1999, pp. 3268-3276
Authors:
Barlier, A
Pellegrini-Bouiller, I
Gunz, G
Zamora, AJ
Jaquet, P
Enjalbert, A
Citation: A. Barlier et al., Impact of gsp oncogene on the expression of genes coding for G(s)alpha, Pit-1, G(i)2 alpha, and somatostatin receptor 2 in human somatotroph adenomas: Involvement in octreotide sensitivity, J CLIN END, 84(8), 1999, pp. 2759-2765
Authors:
Pellegrini-Bouiller, I
Manrique, C
Gunz, G
Grino, M
Zamora, AJ
Figarella-Branger, D
Grisoli, F
Jaquet, P
Enjalbert, A
Citation: I. Pellegrini-bouiller et al., Expression of the members of the Ptx family of transcription factors in human pituitary adenomas, J CLIN END, 84(6), 1999, pp. 2212-2220
Authors:
Saveanu, A
Barlier, A
De Boissezon, C
Kertesz, G
Jean, F
Argemi, B
Cailla, H
Jaquet, P
Citation: A. Saveanu et al., Evaluation of immunoradiometric succinylated. ACTH assay, ANN ENDOCR, 60(5), 1999, pp. 414-421
Authors:
Vallette, S
Pellegrini-Bouiller, I
Jaquet, P
Enjalbert, A
Brue, T
Citation: S. Vallette et al., Transcription factors of the anterior pituitary and combined hypopituitarism, ANN ENDOCR, 60(3), 1999, pp. 216-223
Authors:
Jaquet, P
Citation: P. Jaquet, Acromegaly: Comments on follow-up in 104 patients., ANN ENDOCR, 59(5), 1998, pp. 425-429
Authors:
Jaquet, P
Morange-Rahos, I
Janano, B
Moati, P
Brue, T
Citation: P. Jaquet et al., Somatostatin agonists in the treatment of acromegaly., ANN ENDOCR, 59(4), 1998, pp. 301-304
Authors:
Jaquet, P
Citation: P. Jaquet, Administrating a 1-month long acting release formulation of lanreotide: preliminary results, ANN ENDOCR, 59, 1998, pp. 33-33
Risultati:
1-17
|